Cargando…
慢性髓性白血病酪氨酸激酶抑制剂治疗后出现Ph(−)细胞染色体异常八例临床观察
OBJECTIVE: To observe the clinical features, characteristics and outcomes of chromosomal abnormalities in Philadelphia negative cells (Ph(−)CA) of chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitor (TKI), and provide the evidence for clinical treatment. METHODS: We collec...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348300/ https://www.ncbi.nlm.nih.gov/pubmed/27210877 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.05.011 |
Ejemplares similares
-
酪氨酸激酶抑制剂治疗期间PH(−)细胞出现克隆性染色体异常对慢性髓性白血病患者预后的影响
Publicado: (2019) -
酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
Publicado: (2019) -
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
Publicado: (2022) -
慢性髓性白血病酪氨酸激酶抑制剂治疗过程中继发Ph染色体阴性急性早幼粒细胞白血病一例
Publicado: (2021) -
酪氨酸激酶抑制剂时代成人Ph染色体阳性急性淋巴细胞白血病的治疗进展
Publicado: (2020)